Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators

(2012) Stephen D. Lawn et al.   AIDS

Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy

(2012) S. D. Lawn et al.   CLINICAL INFECTIOUS DISEASES

Determinants of Early and Late Mortality Among HIV-Infected Individuals Receiving Home-Based Antiretroviral Therapy in Rural Uganda

(2011) David M. Moore et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa

(2011) Ingrid V. Bassett et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

(2011) Taraz Samandari et al.   LANCET

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

(2011) Stephen D. Lawn et al.   PLOS MEDICINE

Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study

(2011) Barbara Amuron et al.   AIDS Research and Therapy

Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa

(2010) Stephanus Komati et al.   AIDS

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

(2010) Andrew Boulle et al.   AIDS

Outcomes after virologic failure of first-line ART in South Africa

(2010) Richard A Murphy et al.   AIDS

The tuberculosis challenge in a rural South African HIV programme

(2010) Catherine F Houlihan et al.   BMC INFECTIOUS DISEASES

Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies

(2010) Annelies Van Rie et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The HIV-associated tuberculosis epidemic—when will we act?

(2010) Anthony D Harries et al.   LANCET

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

(2010) Monika Müller et al.   LANCET INFECTIOUS DISEASES

The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis

(2010) Masja Straetemans et al.   PLoS One

Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa

(2010) Martin W. G. Brinkhof et al.   PLoS One

The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study

(2010) Ted Cohen et al.   PLOS MEDICINE

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

(2009) Stephen D Lawn et al.   AIDS

Effect of pulmonary tuberculosis on mortality in patients receiving HAART

(2009) Daniel Westreich et al.   AIDS

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

(2009) Stephen D Lawn et al.   AIDS

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

(2009) Stephen D Lawn et al.   AIDS

Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings

(2009) Stephen D. Lawn et al.   CLINICS IN CHEST MEDICINE

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

(2008) Stephen D Lawn et al.   AIDS